Deutsche Bank’s Lexeo Therapeutics LXEO Stock Holding History

Deutsche Bank’s Portfolio LXEO Stock Details LXEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$249K	Sell	73,581 -8,712	-11%	-$39.4K	﹤0.01%	2981
2026 Q2	$383K	Buy	82,293 +19,242	+31%	+$104K	﹤0.01%	2918
2026 Q1	$362K	Buy	63,051 +5,885	+10%	+$41.7K	﹤0.01%	2741
2025 Q4	$568K	Buy	57,166 +32,844	+135%	+$300K	﹤0.01%	2502
2025 Q3	$161K	Buy	24,322 +400	+2%	+$1.93K	﹤0.01%	3160
2025 Q2	$96.2K	Buy	23,922 +12,552	+110%	+$41.3K	﹤0.01%	3273
2025 Q1	$39.5K	Sell	11,370 -1,856	-14%	-$8.22K	﹤0.01%	3414
2024 Q4	$87K	Buy	13,226 +8,378	+173%	+$66K	﹤0.01%	3323
2024 Q3	$43.8K	Buy	4,848 +288	+6%	+$3.43K	﹤0.01%	3389
2024 Q2	$73.1K	Buy	+4,560	New	+$66.2K	﹤0.01%	3228

Other funds holding LXEO

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Deutsche Bank's LXEO Position: Q3 2026 in Review

Deutsche Bank reduced its Lexeo Therapeutics (LXEO) stake by 11% in Q3 2026, selling an estimated $39.4K and leaving 73,581 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2981.

Deutsche Bank first reported a position in LXEO in Q2 2024 and has held it in 10 quarters since. The position peaked at $568K in Q4 2025. 45 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

Deutsche Bank held 73,581 shares of Lexeo Therapeutics worth $249K as of Q3 2026.
Deutsche Bank sold 8,712 Lexeo Therapeutics shares in Q3 2026, an estimated $39.4K.
Lexeo Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2981 holding.
Deutsche Bank first reported a position in Lexeo Therapeutics in Q2 2024 and has held it in 10 quarters since.
Deutsche Bank's Lexeo Therapeutics position peaked at $568K in Q4 2025.
45 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.